Diansan Su, John Riley, William M Armstead, Renyu Liu
Index: Anesth. Analg. 114(1) , 200-4, (2012)
Full Text: HTML
Cerebral hypoxia/ischemia during infant congenital heart surgery is not uncommon and may induce devastating neurologic disabilities persistent over the lifespan. Hypoxia/ischemia-induced cerebrovascular dysfunction is thought to be an important contributor to neurological damage. No pharmacological agents have been found to prevent this. Mitogen activated protein kinase (MAPK), including extracellular signal regulated kinase (ERK), c-Jun-N-terminal kinase, and p38, is thought to contribute to ischemic preconditioning. We investigated whether pretreatment with salvinorin A, the only natural nonopioid κ receptor agonist, could preserve autoregulation of the pial artery via MAPK.The response of the pial artery to hypotension and hypercapnia was monitored in piglets equipped with a closed cranial window before and after hypoxia and ischemia in the presence or absence of U0126, an inhibitor for the protein kinase upstream of ERK, sp600125, an inhibitor of c-Jun-N-terminal kinase or sb203580, an inhibitor of p38. Salvinorin A (10 μg/kg IV) was administered 30 minutes before hypoxia/ischemia in salvinorin-treated animals. Cerebrospinal fluid samples were collected before and 30 minutes after salvinorin A administration for the measurement of MAPK. Data (n = 5) were analyzed by repeated-measures analysis of variance.Pial artery dilation to hypercapnia and hypotension was blunted after hypoxia/ ischemia but preserved well by pretreatment with salvinorin A. U0126, but not sp600125 or sb203580, abolished the preservative effects of salvinorin A on cerebral vascular autoregulation to hypotension and hypercapnia. The ratio of pERK/ERK in cerebrospinal fluid increased significantly in salvinorin-treated animals, which was inhibited by U0126.Salvinorin A pretreatment preserves autoregulation of the pial artery to hypotension and hypercapnia after hypoxia/ischemia via ERK in a piglet model.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Salvinorin A(Divinorin A)
CAS:83729-01-5 |
C23H28O8 |
Novel orally available salvinorin A analog PR-38 inhibits ga...
2014-07-01 [J. Pharmacol. Exp. Ther. 350(1) , 69-78, (2014)] |
Regulating a novel drug: an evaluation of changes in use of ...
2012-11-01 [Int. J. Drug Policy 23(6) , 512-21, (2012)] |
Development of an enzyme immunoassay using a monoclonal anti...
2013-09-27 [J. Nat. Prod. 76(9) , 1654-60, (2013)] |
Differential signaling properties at the kappa opioid recept...
2012-01-15 [Bioorg. Med. Chem. Lett. 22(2) , 1023-6, (2012)] |
Analysis of Salvinorin A in urine using microextraction in p...
2013-03-01 [Bioanalysis 5(6) , 661-8, (2013)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved